Printer Friendly

BIO-VASCULAR REPORTS DISPUTE ON ROYALTIES

 BIO-VASCULAR REPORTS DISPUTE ON ROYALTIES
 ST. PAUL, Minn., July 31 /PRNewswire/ -- Bio-Vascular, Inc.


(NASDAQ: BVAS) said today that it had served an answer and counterclaim to a lawsuit brought by Bioplasty, Inc., (NASDAQ: BIOP) against Bio- Vascular on July 14.
 Bioplasty brought a lawsuit to compel payment of a quarterly royalty. Bio-Vascular had not paid the royalty while investigating whether the royalty agreement was valid. Bio-Vascular has since paid the royalty under protest and will pay all future royalties under protest until the dispute is settled.
 In its answer and counterclaim, Bio-Vascular alleges, among other claims, that the original consideration paid and the royalties are excessive and that the contracts were the result of non-arm's-length transactions. The counterclaim seeks, among other remedies, to void the disputed contract and to have Bioplasty return all past payments.
 Bio-Vascular, Inc., based in St. Paul, is a manufacturer and marketer of proprietary consumable medical products for cardiac and vascular surgery.
 -0- 7/31/92
 /CONTACT: Curt Swenson of Swenson Falker Eilertsen, 612-371-0000, for Bio-Vascular, or John H. Darnall or M. Karen Gilles, 612-631-3529, both of Bio-Vascular/
 (BVAS BIOP) CO: Bio-Vascular, Inc.; Bioplasty, Inc. ST: Minnesota IN: MTC SU:


AL -- MN012 -- 5752 07/31/92 16:18 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 31, 1992
Words:203
Previous Article:COLUMBIA GAS COMPANIES GRANTED ADDITIONAL TIME TO FILE REORGANIZATION PLANS
Next Article:ANDREW CORP. ANNOUNCES RESULTS OF TENDER OFFER
Topics:


Related Articles
BIO-VASCULAR ANNOUNCES NEW VICE PRESIDENT OF OPERATIONS
BIO-VASCULAR WILL BEGIN CLINICAL TRIALS OF SMALL DIAMETER GRAFT
BIO-VASCULAR REPORTS FIRST QUARTER GAINS IN SALES AND NET INCOME
BIO-VASCULAR REPORTS GAINS IN THIRD QUARTER SALES, NET INCOME
BIO-VASCULAR REPORTS 2ND QUARTER RESULTS
BIO-VASCULAR REPORTS HIGHER INCOME IN THIRD QUARTER
VITAL IMAGES AGREES IN PRINCIPLE TO MERGER INTO BIO-VASCULAR, INC.
Bio-Vascular Announces Record Date for Vital Images Spin-Off
Bio-Vascular Files With FDA for Flo-Thru Intraluminal Shunt
Bio-Vascular Gets 'CE' Mark for Two Surgical Tools

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters